This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Riken Corporation, Sysmex Corporation, The Jikei University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 890 
1 out of 1,055 
1 out of 8 Years Active: 2022
Title: Kozo Suto: Innovator in Monoclonal Antibody Research
Introduction
Kozo Suto is a prominent inventor based in Kobe, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for medical research and therapeutic applications.
Latest Patents
Kozo Suto holds a patent for an isolated monoclonal antibody against a human Transforming Growth Factor-β (TGF-β) Latency Associated Protein (LAP) degradate. This innovative antibody is capable of recognizing an integrin binding site in the human TGF-β LAP degradate. His patent represents a crucial advancement in understanding and potentially treating conditions related to TGF-β.
Career Highlights
Throughout his career, Kozo Suto has worked with esteemed organizations such as Riken Corporation and The Jikei University. His experience in these institutions has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in his field.
Collaborations
Kozo Suto has collaborated with notable colleagues, including Ikuyo Inoue and Soichi Kojima. These partnerships have fostered a rich environment for innovation and research, enhancing the impact of their collective work.
Conclusion
Kozo Suto's contributions to monoclonal antibody research exemplify the importance of innovation in biotechnology. His patent and collaborations highlight his role as a key figure in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile